NASDAQ:XRAY - Dentsply Sirona Stock Price, Price Target & More

$49.60 +0.26 (+0.53 %)

(As of 04/23/2018 11:06 AM ET)

Previous Close$49.34

Today's Range$49.13 - $49.81

52-Week Range$48.25 - $68.98

Volume278,357 shs

Average Volume2.35 million shs

Market Capitalization$11.22 billion

P/E Ratio18.55

Dividend Yield0.70%

Beta1.26

About Dentsply Sirona (NASDAQ:XRAY)

DENTSPLY SIRONA Inc. designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. The company also offers dental laboratory products, such as dental prosthetics that include artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials. In addition, it provides dental technology products, including dental implants and related scanning equipment, treatment software, and orthodontic appliances for dental practitioners and specialist, and dental laboratories; and dental equipment, such as treatment centers, imaging equipment, and computer aided design and machining systems for dental practitioners and laboratories. Further, the company offers healthcare consumable products, such as urology catheters, various surgical products, medical drills, and other non-medical products. It markets and sells dental products through distributors, dealers, and importers to dentists, dental hygienists, dental assistants, dental laboratories, and dental schools; and urology products directly to patients, as well as through distributors to urologists, urology nurses, and general practitioners. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1899 and is headquartered in York, Pennsylvania.

Receive XRAY News and Ratings via Email

Sign-up to receive the latest news and ratings for XRAY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Dental equipment & supplies

Sub-IndustryHealth Care Supplies

SectorMedical

SymbolNASDAQ:XRAY

CUSIP24903010

Webwww.dentsplysirona.com

Phone717-845-7511

Debt

Debt-to-Equity Ratio0.24%

Current Ratio2.10%

Quick Ratio1.45%

Price-To-Earnings

Trailing P/E Ratio18.55

Forward P/E Ratio18.24

P/E Growth2.17

Sales & Book Value

Annual Sales$3.99 billion

Price / Sales2.82

Cash Flow$11.2984 per share

Price / Cash4.39

Book Value$28.86 per share

Price / Book1.72

Profitability

EPS (Most Recent Fiscal Year)$2.66

Net Income$-1,550,000,000.00

Net Margins-39.39%

Return on Equity8.35%

Return on Assets5.61%

Miscellaneous

Employees16,100

Outstanding Shares227,370,000

How to Become a New Pot Stock Millionaire

Dentsply Sirona (NASDAQ:XRAY) Frequently Asked Questions

What is Dentsply Sirona's stock symbol?

Dentsply Sirona trades on the NASDAQ under the ticker symbol "XRAY."

How often does Dentsply Sirona pay dividends? What is the dividend yield for Dentsply Sirona?

Dentsply Sirona announced a quarterly dividend on Wednesday, February 14th. Investors of record on Thursday, March 29th will be paid a dividend of $0.0875 per share on Friday, April 13th. This represents a $0.35 dividend on an annualized basis and a dividend yield of 0.71%. The ex-dividend date is Wednesday, March 28th. View Dentsply Sirona's Dividend History.

How were Dentsply Sirona's earnings last quarter?

Dentsply Sirona (NASDAQ:XRAY) issued its quarterly earnings data on Thursday, March, 1st. The medical instruments supplier reported $0.82 EPS for the quarter, beating the Zacks' consensus estimate of $0.81 by $0.01. The medical instruments supplier had revenue of $1.09 billion for the quarter, compared to analysts' expectations of $1.06 billion. Dentsply Sirona had a positive return on equity of 8.35% and a negative net margin of 39.39%. Dentsply Sirona's revenue was up 9.5% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.67 EPS. View Dentsply Sirona's Earnings History.

When is Dentsply Sirona's next earnings date?

Dentsply Sirona is scheduled to release their next quarterly earnings announcement on Tuesday, May, 8th 2018. View Earnings Estimates for Dentsply Sirona.

What price target have analysts set for XRAY?

14 brokers have issued 12-month price targets for Dentsply Sirona's stock. Their forecasts range from $55.00 to $81.00. On average, they expect Dentsply Sirona's share price to reach $67.00 in the next year. View Analyst Ratings for Dentsply Sirona.

What are Wall Street analysts saying about Dentsply Sirona stock?

Here are some recent quotes from research analysts about Dentsply Sirona stock:

1. Jefferies Group LLC analysts commented, "Dynavax provided Phase 1b/2 updates on TLR9 agonist, SD-101 in combination with Keytruda, for head and neck squamous cell carcinoma (HNSCC) and metastatic melanoma at AACR." (4/16/2018)
2. Barrington Research analysts commented, "We are currently modeling adjusted EPS of $2.70 and this is unchanged versus our previous modeling. We suspect that the company will be able to overcome whatever modest dilution comes with this deal over the balance of 2018. That said, we have made some modest adjustments to our quarterly modeling and have attached a model, which is a bit more back-end loaded than previously. We are doing this in part to account for any additional costs associated with the efforts to put this transaction together as well as general conservatism associated with prior disclosures by management relative to the company’s ongoing efforts to work down its inventory levels with certain key distribution channels." (3/27/2018)
3. According to Zacks Investment Research, "Over the last year, DENTSPLY SIRONA traded below the broader industry in terms of prices. The company's higher capital expenditure on product development and tough competition are expected to put margins under pressure. Unfavorable foreign exchange rate and integration risks are the major headwinds in the near term. However robust performance by the company’s flagship dental implants, CAD/CAM systems, imaging systems, treatment centers and orthodontic product platforms hold considerable promise over the long haul. Emerging markets like Asia-Pacific & the Middle East offer healthy growth opportunities on a long-term basis, as they remain vastly untapped with low dental products penetration. The company’s agreements with MedTech bigwigs Patterson Companies in Canada are likely to drive sales. DENTSPLY SIRONA has recently witnessed a rebound in sales in Asia, particularly Japan, and strong growth in Russia. Over the last year, DENTSPLY" (1/8/2018)

Who are some of Dentsply Sirona's key competitors?

Some companies that are related to Dentsply Sirona include Zimmer Biomet (ZBH), Mylan (MYL), Align Technology (ALGN), AmerisourceBergen (ABC), Sunny Optical Technology (Group) (SNPTF), Cardinal Health (CAH), Centene (CNC), Cerner (CERN), Eisai (ESALY), Lonza Group (LZAGY), Teva Pharmaceutical Industries (TEVA), Idexx Laboratories (IDXX), Coloplast (CLPBY), Smith & Nephew (SNN), Laboratory Corp. of America (LH), Sino Biopharmaceut (SBMFF), UCB (UCBJF) and Incyte (INCY).

Who are Dentsply Sirona's key executives?

Dentsply Sirona's management team includes the folowing people:

Ms. Maureen J. MacInnis, Chief HR Officer & Sr. VP (Age 57)
Mr. Donald M. Casey Jr., CEO & Director (Age 58)
Mr. Nicholas William Alexos, Principal Accounting Officer, Exec. VP & CFO (Age 54)
Mr. Robert J. Size, Interim Pres & COO (Age 59)
Mr. Keith J. Ebling, EVP, Gen. Counsel & Sec. (Age 49)

Has Dentsply Sirona been receiving favorable news coverage?

Media coverage about XRAY stock has been trending somewhat positive this week, Accern reports. The research group ranks the sentiment of news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Dentsply Sirona earned a coverage optimism score of 0.03 on Accern's scale. They also assigned headlines about the medical instruments supplier an impact score of 45.70 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next few days.

How do I buy shares of Dentsply Sirona?

Shares of XRAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Dentsply Sirona's stock price today?

One share of XRAY stock can currently be purchased for approximately $49.58.

How big of a company is Dentsply Sirona?

Dentsply Sirona has a market capitalization of $11.22 billion and generates $3.99 billion in revenue each year. The medical instruments supplier earns $-1,550,000,000.00 in net income (profit) each year or $2.66 on an earnings per share basis. Dentsply Sirona employs 16,100 workers across the globe.

How can I contact Dentsply Sirona?

Dentsply Sirona's mailing address is 221 WEST PHILADELPHIA STREET, YORK PA, 17401. The medical instruments supplier can be reached via phone at 717-845-7511 or via email at [email protected]

MarketBeat Community Rating for Dentsply Sirona (XRAY)

Community Ranking:		2.5 out of 5 ( )
Outperform Votes:		251 (Vote Outperform)
Underperform Votes:		247 (Vote Underperform)
Total Votes:		498

MarketBeat's community ratings are surveys of what our community members think about Dentsply Sirona and other stocks. Vote "Outperform" if you believe XRAY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe XRAY will underperform the S&P 500 over the long term. You may vote once every thirty days.

Dentsply Sirona (NASDAQ:XRAY) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

14 Wall Street analysts have issued ratings and price targets for Dentsply Sirona in the last 12 months. Their average twelve-month price target is $67.00, suggesting that the stock has a possible upside of 35.08%. The high price target for XRAY is $81.00 and the low price target for XRAY is $55.00. There are currently 1 sell rating, 4 hold ratings and 9 buy ratings for the stock, resulting in a consensus rating of "Buy."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Buy	Buy	Buy	Buy
Consensus Rating Score:	2.57	2.57	2.54	2.50
Ratings Breakdown:	1 Sell Rating(s) 4 Hold Rating(s) 9 Buy Rating(s) 0 Strong Buy Rating(s)	1 Sell Rating(s) 4 Hold Rating(s) 9 Buy Rating(s) 0 Strong Buy Rating(s)	1 Sell Rating(s) 4 Hold Rating(s) 8 Buy Rating(s) 0 Strong Buy Rating(s)	1 Sell Rating(s) 3 Hold Rating(s) 6 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$67.00	$67.0769	$68.9167	$64.8889
Price Target Upside:	35.08% upside	18.87% upside	10.00% upside	6.95% upside

Dentsply Sirona (NASDAQ:XRAY) Consensus Price Target History

Price Target History for Dentsply Sirona (NASDAQ:XRAY)

Dentsply Sirona (NASDAQ:XRAY) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/16/2018	Jefferies Group	Reiterated Rating	Buy		Low
4/5/2018	Cleveland Research	Reiterated Rating	Hold		Low
3/27/2018	Barrington Research	Reiterated Rating	Buy	$69.00	Medium
3/27/2018	HC Wainwright	Set Price Target	Hold	$63.00	Medium
3/8/2018	Barclays	Initiated Coverage	Equal Weight -> Equal Weight	$62.00	Low
3/5/2018	JPMorgan Chase	Lower Price Target	Overweight -> Overweight	$75.00 -> $70.00	Low
3/2/2018	Credit Suisse Group	Lower Price Target	Outperform -> Outperform	$73.00 -> $69.00	High
12/8/2017	Deutsche Bank	Initiated Coverage	Buy -> Buy	$81.00	Low
11/28/2017	Stephens	Initiated Coverage	Overweight	$75.00	Low
11/6/2017	Stifel Nicolaus	Boost Price Target	Buy	$66.00 -> $70.00	N/A
10/19/2017	Robert W. Baird	Set Price Target	Buy	$63.00	N/A
10/6/2017	Morgan Stanley	Reiterated Rating	Overweight	$67.00 -> $69.00	N/A
8/10/2017	UBS	Reiterated Rating	Neutral	$62.00 -> $59.00	Low
5/23/2017	Goldman Sachs	Downgrade	Neutral -> Sell	$60.00 -> $55.00	Medium
9/12/2016	Bank of America	Initiated Coverage	Buy	$70.00	N/A
6/27/2016	Piper Jaffray	Reiterated Rating	Buy		N/A

(Data available from 4/23/2016 forward)

Dentsply Sirona (NASDAQ:XRAY) Earnings History and Estimates Chart

Earnings by Quarter for Dentsply Sirona (NASDAQ:XRAY)

Dentsply Sirona (NASDAQ:XRAY) Earnings Estimates

2018 EPS Consensus Estimate: $2.73
2019 EPS Consensus Estimate: $3.00

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	4	$0.42	$0.43	$0.43
Q2 2018	4	$0.65	$0.69	$0.67
Q3 2018	4	$0.75	$0.77	$0.76
Q4 2018	4	$0.86	$0.89	$0.87
Q1 2019	3	$0.50	$0.65	$0.58
Q2 2019	3	$0.74	$0.79	$0.76
Q3 2019	3	$0.77	$0.84	$0.80
Q4 2019	3	$0.80	$0.97	$0.87

Dentsply Sirona (NASDAQ XRAY) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
5/7/2018		$0.53					N/A
3/1/2018	Q4 2017	$0.81	$0.82	$1.0607 billion	$1.0910 billion	View	Listen
11/3/2017	Q3 2017	$0.66	$0.70	$978.99 million	$1.0092 billion	View	N/A
8/9/2017	Q2 2017	$0.65	$0.65	$1.0032 billion	$992.70 million	View	Listen
5/9/2017	Q1 17	$0.50	$0.49	$916.55 million	$900.50 million	View	Listen
2/17/2017	Q4 2016	$0.65	$0.67	$1.0192 billion	$996.50 million	View	Listen
11/4/2016	Q316	$0.63	$0.66	$967.68 million	$954.20 million	View	Listen
8/5/2016	Q216	$0.70	$0.76	$1.03 billion	$1.02 billion	View	Listen
5/6/2016	Q1	$0.63	$0.69	$741.80 million	$772.60 million	View	N/A
2/12/2016	Q415	$0.65	$0.65	$687.35 million	$671.10 million	View	Listen
10/28/2015	Q3	$0.63	$0.66	$667.00 million	$648.90 million	View	Listen
7/30/2015	Q215	$0.68	$0.73	$715.49 million	$698.00 million	View	Listen
5/6/2015	Q115	$0.57	$0.59	$690.16 million	$656.30 million	View	Listen
2/18/2015	Q414	$0.61	$0.60	$751.04 million	$719.00 million	View	Listen
10/29/2014	Q314	$0.60	$0.62	$725.83 million	$708.00 million	View	Listen
7/31/2014	Q2	$0.68	$0.69	$782.86 million	$765.20 million	View	Listen
5/6/2014	Q1	$0.56	$0.59	$747.27 million	$730.10 million	View	Listen
2/18/2014	Q4	$0.61	$0.61	$767.89 million	$753.70 million	View	Listen
10/29/2013	Q313	$0.56	$0.57	$716.13 million	$704.00 million	View	Listen
8/1/2013	Q2 2013	$0.65	$0.66	$782.73 million	$761.00 million	View	Listen
5/9/2013	Q1 2013	$0.56	$0.52	$732.87 million	$732.10 million	View	Listen
2/20/2013	Q4 2012	$0.56	$0.56	$748.56 million	$753.30 million	View	Listen
10/25/2012		$0.50	$0.51			View	N/A
7/31/2012		$0.57	$0.62			View	N/A
5/1/2012		$0.52	$0.52			View	N/A
2/16/2012		$0.52	$0.51			View	N/A
10/27/2011		$0.43	$0.46			View	N/A
7/28/2011		$0.51	$0.55			View	N/A
4/28/2011		$0.48	$0.49			View	N/A
2/9/2011		$0.50	$0.51			View	N/A
10/28/2010	Q3 2010	$0.45	$0.45			View	N/A
7/29/2010	Q2 2010	$0.51	$0.50			View	N/A
4/29/2010	Q1 2010	$0.45	$0.44			View	N/A
2/10/2010	Q4 2009	$0.48	$0.48			View	N/A
10/28/2009	Q3 2009	$0.44	$0.44			View	N/A
7/29/2009	Q2 2009	$0.48	$0.49			View	N/A
4/30/2009	Q1 2009	$0.43	$0.43			View	N/A
2/4/2009	Q4 2008	$0.46	$0.45			View	N/A
10/28/2008	Q3 2008	$0.44	$0.46			View	N/A
7/29/2008	Q2 2008	$0.49	$0.53			View	N/A
4/30/2008	Q1 2008	$0.43	$0.45			View	N/A
2/5/2008	Q4 2007	$0.44	$0.46			View	N/A

(Earnings results data provided by Zacks Investment Research)

Dentsply Sirona (NASDAQ:XRAY) Dividend Information

Dentsply Sirona pays an annual dividend of $0.35 per share, with a dividend yield of 0.71%. XRAY's most recent quarterly dividend payment was Friday, April 13. Dentsply Sirona pays out 13.16% of its earnings out as a dividend.

Most Recent Dividend:	4/13/2018
Annual Dividend:	$0.35
Dividend Yield:	0.71%
Payout Ratio:	13.16% (Trailing 12 Months of Earnings) 12.87% (Based on This Year's Estimates) 11.59% (Based on Next Year's Estimates)

Dividend Payments by Quarter for Dentsply Sirona (NASDAQ:XRAY)

Dentsply Sirona (NASDAQ:XRAY) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
2/14/2018	quarterly	$0.0875	0.7%	3/28/2018	3/29/2018	4/13/2018
12/12/2017	quarterly	$0.0875	0.53%	12/28/2017	12/29/2017	1/12/2018
6/28/2017	quarterly	$0.0875	0.54%	9/28/2017	9/29/2017	10/13/2017
6/22/2017	quarterly	$0.0875	0.55%	6/28/2017	6/30/2017	7/14/2017
2/17/2017	quarterly	$0.0875	0.56%	3/29/2017	3/31/2017	4/13/2017
12/15/2016	quarterly	$0.0775	0.52%	12/28/2016	12/30/2016	1/13/2017
9/22/2016		$0.0775		9/28/2016	9/30/2016	10/14/2016
4/11/2016		$0.0780		6/22/2016	6/24/2016	7/8/2016
3/3/2016		$0.0780		3/22/2016	3/25/2016	4/8/2016
10/1/2015		$0.0720		12/22/2015	12/25/2015	1/8/2016
7/29/2015	quarterly	$0.0725		9/23/2015	9/25/2015	10/9/2015
5/20/2015	quarterly	$0.0725	0.55%	6/24/2015	6/26/2015	7/10/2015
2/24/2015	quarterly	$0.0725	0.54%	3/25/2015	3/27/2015	4/10/2015
9/25/2014	quarterly	$0.0663	0.58%	12/23/2014	12/26/2014	1/9/2015
8/1/2014	quarterly	$0.0663	0.57%	9/24/2014	9/26/2014	10/10/2014
5/22/2014	quarterly	$0.0663	0.57%	6/25/2014	6/27/2014	7/11/2014
2/18/2014	quarterly	$0.0663	0.59%	3/26/2014	3/28/2014	4/11/2014
9/27/2013	quarterly	$0.0625	0.58%	12/24/2013	12/27/2013	1/10/2014
8/1/2013	quarterly	$0.0625	0.58%	9/25/2013	9/27/2013	10/11/2013
5/23/2013	quarterly	$0.0625	0.6%	6/26/2013	6/28/2013	7/12/2013
2/27/2013	quarterly	$0.0625	0.61%	3/26/2013	3/29/2013	4/12/2013

(Data available from 1/1/2013 forward)

Dentsply Sirona (NASDAQ XRAY) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.93%
Institutional Ownership Percentage: 97.89%

Insider Trading History for Dentsply Sirona (NASDAQ:XRAY)

Institutional Ownership by Quarter for Dentsply Sirona (NASDAQ:XRAY)

Dentsply Sirona (NASDAQ XRAY) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/8/2018	Eric Brandt	Director	Sell	6,409	$68.04	$436,068.36	12,073
11/13/2017	Francis J Lunger	Director	Sell	8,900	$65.90	$586,510.00
11/13/2017	Mark Thierer	Insider	Buy	77,000	$66.04	$5,085,080.00
11/13/2017	Nicholas W Alexos	CFO	Buy	50,000	$65.85	$3,292,500.00
4/24/2017	James G Mosch	CEO	Sell	50,600	$63.49	$3,212,594.00	105,083
4/7/2017	Christopher T Clark	CEO	Sell	89,700	$62.67	$5,621,499.00	112,067
3/9/2017	Ulrich Michel	Insider	Sell	24,000	$62.84	$1,508,160.00	94,067
3/2/2017	Eric Brandt	Director	Sell	2,941	$64.35	$189,253.35	4,722
3/1/2017	Bret W Wise	Insider	Sell	146,900	$64.17	$9,426,573.00	142,121
2/17/2017	Arthur D Kowaloff	Director	Sell	27,213	$62.00	$1,687,206.00	55,692
2/17/2017	Christopher T Clark	CEO	Sell	64,500	$60.70	$3,915,150.00	55,916
11/17/2016	James G Mosch	CEO	Sell	30,400	$60.93	$1,852,272.00	75,283
9/6/2016	Rainer Berthan	VP	Sell	5,000	$61.12	$305,600.00	34,370
8/25/2016	Maureen J Macinnis	SVP	Sell	45,100	$60.55	$2,730,805.00	36,730
8/23/2016	Maureen J Macinnis	SVP	Sell	17,650	$60.61	$1,069,766.50	19,630
6/2/2016	Rainer Berthan	VP	Sell	6,464	$62.56	$404,387.84	39,341
5/26/2016	Michael C Alfano	Director	Sell	3,000	$61.58	$184,740.00	8,758
5/16/2016	Harry M Jansen Kraemer Jr	Director	Sell	27,213	$62.17	$1,691,832.21	58,262
3/29/2016	Arthur D Kowaloff	Director	Sell	13,006	$62.00	$806,372.00	42,785
11/18/2015	Deborah Rasin	VP	Sell	4,500	$60.56	$272,520.00	4,429
11/4/2015	Michael C Alfano	Director	Sell	2,500	$62.15	$155,375.00	8,737
11/3/2015	Deborah Rasin	VP	Sell	14,000	$61.70	$863,800.00	8,929
3/30/2015	Christopher T Clark	Insider	Sell	85,566	$51.18	$4,379,267.88
2/20/2015	Deborah Rasin	VP	Sell	11,000	$52.47	$577,170.00
2/20/2015	Michael J Coleman	Director	Sell	18,000	$52.47	$944,460.00
1/9/2015	Robert J Size	VP	Sell	9,200	$52.97	$487,324.00
12/8/2014	Leslie A Jones	Director	Sell	18,000	$55.45	$998,100.00
12/4/2014	Albert Sterkenburg	VP	Sell	23,200	$55.62	$1,290,384.00
11/7/2014	Michael C Alfano	Director	Sell	20,000	$51.23	$1,024,600.00
11/5/2014	James G Mosch	VP	Sell	55,042	$51.25	$2,820,902.50
11/4/2014	Francis J Lunger	Director	Sell	9,160	$50.90	$466,244.00
10/31/2014	Albert Sterkenburg	VP	Sell	2,000	$50.51	$101,020.00
10/31/2014	John C Miles II	Director	Sell	20,000	$50.65	$1,013,000.00
8/25/2014	Leslie A Jones	Director	Sell	2,000	$48.30	$96,600.00
7/3/2014	Christopher T Clark	Insider	Sell	27,521	$47.74	$1,313,852.54
5/30/2014	Michael C Alfano	Director	Sell	2,764	$47.25	$130,599.00
5/19/2014	Leslie Jones	Director	Sell	2,000	$46.49	$92,980.00	95,892
5/12/2014	Robert Size	VP	Sell	5,049	$46.29	$233,718.21	11,588
12/11/2013	Bret Wise	Chairman	Sell	90,000	$48.50	$4,365,000.00	21,724
12/9/2013	Francis Lunger	Director	Sell	18,000	$47.66	$857,880.00	4,322
12/6/2013	Bret Wise	Chairman	Sell	24,323	$47.66	$1,159,234.18	30,294
12/2/2013	Bret Wise	Chairman	Sell	66,761	$47.53	$3,173,150.33	30,294
12/2/2013	William Hecht	Director	Sell	18,000	$47.49	$854,820.00	18,000
11/8/2013	Leslie Jones	Director	Sell	2,000	$47.68	$95,360.00	97,892
10/21/2013	Robert J Size	VP	Sell	14,262	$46.00	$656,052.00
9/11/2013	Robert Size	VP	Sell	8,200	$45.00	$369,000.00	11,501
9/10/2013	James G Mosch	VP	Sell	41,836	$43.95	$1,838,692.20
7/31/2013	Christopher T Clark	Insider	Sell	20,918	$43.00	$899,474.00
7/31/2013	Eric Brandt	Director	Sell	18,000	$43.00	$774,000.00
7/9/2013	Christopher T Clark	Insider	Sell	20,918	$42.00	$878,556.00
6/3/2013	Leslie A Jones	Director	Sell	2,840	$41.76	$118,598.40
3/12/2013	Paula H Cholmondeley	Director	Sell	9,000	$42.70	$384,300.00
12/21/2012	Bret W Wise	Chairman	Sell	4,349	$40.50	$176,134.50

(Data available from 1/1/2013 forward)

Dentsply Sirona (NASDAQ XRAY) News Headlines

Source:

Date	Headline
	Dentsply Sirona (XRAY) versus Straumann (SAUHF) Financial Review www.americanbankingnews.com - April 23 at 9:14 AM
	Reviewing Straumann (SAUHF) & Dentsply Sirona (XRAY) www.americanbankingnews.com - April 23 at 3:20 AM
	Head-To-Head Analysis: Dentsply Sirona (XRAY) vs. Straumann (SAUHF) www.americanbankingnews.com - April 22 at 7:26 AM
	Dentsply Sirona (XRAY) Given Average Recommendation of "Hold" by Brokerages www.americanbankingnews.com - April 20 at 3:30 AM
	Q2 2018 EPS Estimates for Dentsply Sirona Boosted by Analyst (XRAY) www.americanbankingnews.com - April 18 at 8:12 AM
	Factors of Influence in 2018, Key Indicators and Opportunity within Cerner ... globenewswire.com - April 17 at 8:06 AM
	Jefferies Group Analysts Reduce Earnings Estimates for Dentsply Sirona (XRAY) www.americanbankingnews.com - April 17 at 6:54 AM
	Dentsply Sirona (XRAY) Earns "Buy" Rating from Jefferies Group www.americanbankingnews.com - April 16 at 9:16 PM
	Head-To-Head Review: Biolase (BIOL) & Dentsply Sirona (XRAY) www.americanbankingnews.com - April 16 at 11:38 AM
	Dentsply Sirona: Let The Dip Deepen Before Buying seekingalpha.com - April 16 at 8:02 AM
	Biolase (BIOL) & Dentsply Sirona (XRAY) Financial Contrast www.americanbankingnews.com - April 13 at 11:51 AM
	Active-Investors: Free Post Earnings Research Report: DENTSPLY's Quarterly Sales Jumped 9.5%; Adjusted EPS Advanced 22% www.finanznachrichten.de - April 12 at 5:56 PM
	Free Post Earnings Research Report: DENTSPLY’s Quarterly Sales Jumped 9.5%; Adjusted EPS Advanced 22% finance.yahoo.com - April 12 at 8:03 AM
	Dentsply Sirona (XRAY) Expected to Post Quarterly Sales of $950.06 Million www.americanbankingnews.com - April 11 at 4:51 AM
	Dentsply Sirona (XRAY) Rating Reiterated by HC Wainwright www.americanbankingnews.com - April 10 at 5:38 PM
	Will Dentsply Sirona Stock Recover from Recent Declines? finance.yahoo.com - April 10 at 8:08 AM
	Dentsply Sirona (XRAY) Expected to Announce Earnings of $0.44 Per Share www.americanbankingnews.com - April 9 at 5:23 AM
	HC Wainwright Reiterates Buy Rating for Dentsply Sirona (XRAY) www.americanbankingnews.com - April 8 at 11:04 AM
	DENTSPLY SIRONA's (XRAY) "Hold" Rating Reiterated at Cleveland Research www.americanbankingnews.com - April 5 at 10:33 AM
	Q1 2018 EPS Estimates for DENTSPLY SIRONA Inc (XRAY) Reduced by Analyst www.americanbankingnews.com - April 4 at 7:04 AM
	Head to Head Comparison: Straumann (SAUHF) & DENTSPLY SIRONA (XRAY) www.americanbankingnews.com - April 3 at 9:20 PM
	DENTSPLY SIRONA (XRAY) Upgraded by Barrington Research to "Outperform" www.americanbankingnews.com - April 1 at 8:42 PM
	FY2020 Earnings Estimate for DENTSPLY SIRONA Inc Issued By William Blair (XRAY) www.americanbankingnews.com - March 29 at 8:46 AM
	Q2 2018 EPS Estimates for DENTSPLY SIRONA Inc (XRAY) Increased by Analyst www.americanbankingnews.com - March 29 at 7:55 AM
	Q1 2018 Earnings Forecast for DENTSPLY SIRONA Inc (XRAY) Issued By William Blair www.americanbankingnews.com - March 28 at 6:38 AM
	DENTSPLY SIRONA Inc (XRAY) Forecasted to Earn Q1 2018 Earnings of $0.42 Per Share www.americanbankingnews.com - March 28 at 6:38 AM
	DENTSPLY to Acquire OraMetrix, Boost CAD-CAM Dental Unit finance.yahoo.com - March 27 at 5:26 PM
	DENTSPLY SIRONA (XRAY) PT Set at $63.00 by HC Wainwright www.americanbankingnews.com - March 27 at 10:01 AM
	DENTSPLY SIRONA (XRAY) Earns "Buy" Rating from Barrington Research www.americanbankingnews.com - March 27 at 9:31 AM
	BidaskClub Lowers DENTSPLY SIRONA (XRAY) to Sell www.americanbankingnews.com - March 26 at 10:58 PM
	Dentsply Sirona (XRAY) Reports Acquisition of Technology Solutions Provider OraMetrix www.streetinsider.com - March 26 at 5:34 PM
	Here's Why You Should Steer Clear of DENTSPLY (XRAY) for Now finance.yahoo.com - March 26 at 5:34 PM
	DENTSPLY SIRONA Inc (XRAY) Receives Average Recommendation of "Hold" from Analysts www.americanbankingnews.com - March 26 at 3:05 AM
	DENTSPLY SIRONA Inc (XRAY) Expected to Announce Quarterly Sales of $961.48 Million www.americanbankingnews.com - March 25 at 8:38 AM
	DENTSPLY SIRONA (XRAY) Downgraded by BidaskClub to Strong Sell www.americanbankingnews.com - March 24 at 7:53 PM
	Worldwide CBCT Dental Imaging Market Financial Overview, Dentistry Sector Top 8 Players Management, Size and Share 2022 Insight www.marketwatch.com - March 24 at 5:28 PM
	DENTSPLY SIRONA Becomes Oversold (XRAY) - Nasdaq www.nasdaq.com - March 23 at 8:05 AM
	Zacks: Brokerages Anticipate DENTSPLY SIRONA Inc (XRAY) Will Announce Earnings of $0.48 Per Share www.americanbankingnews.com - March 23 at 3:22 AM
	Why Innovation Matters to Dentsply Sirona—Now More Than Ever finance.yahoo.com - March 20 at 8:07 AM
	New Strong Sell Stocks for March 19th www.zacks.com - March 19 at 8:05 AM
	Understanding Dentsply Sirona’s New Organizational Structure finance.yahoo.com - March 19 at 8:05 AM
	Behind Dentsply Sirona’s Total Impairment Charges in 2017 finance.yahoo.com - March 16 at 8:02 AM
	Quotidian Technical Highlights on Selected Medical Supplies Stocks -- Baxter, ConforMIS, DENTSPLY SIRONA, and Haemonetics www.bizjournals.com - March 13 at 7:30 PM
	DENTSPLY SIRONA (XRAY) Coverage Initiated by Analysts at Barclays www.americanbankingnews.com - March 9 at 12:43 AM
	Jefferies Group Comments on DENTSPLY SIRONA Inc's Q3 2018 Earnings (XRAY) www.americanbankingnews.com - March 8 at 7:50 AM
	Barrington Research Comments on DENTSPLY SIRONA Inc's Q1 2018 Earnings (XRAY) www.americanbankingnews.com - March 8 at 7:29 AM
	Jefferies Group Research Analysts Lower Earnings Estimates for DENTSPLY SIRONA Inc (XRAY) www.americanbankingnews.com - March 7 at 7:32 AM
	Q1 2018 Earnings Estimate for DENTSPLY SIRONA Inc (XRAY) Issued By William Blair www.americanbankingnews.com - March 7 at 7:26 AM
	Ruane Cunniff Comments on Dentsply Sirona finance.yahoo.com - March 6 at 5:51 PM
	Sequoia Fund Management's Discussion of Fund Performance finance.yahoo.com - March 6 at 5:51 PM

Dentsply Sirona (NASDAQ:XRAY) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Dentsply Sirona (NASDAQ:XRAY) Income Statement, Balance Sheet and Cash Flow Statement

Dentsply Sirona (NASDAQ XRAY) Stock Chart for Monday, April, 23, 2018

Loading chart…

This page was last updated on 4/23/2018 by MarketBeat.com Staff